Work

Cost-Effectiveness Analysis of Exenatide Twice Daily (BID) Versus Insulin Glargine Once Daily (QD) as Add-on Therapy in Chinese Patients with Type 2 Diabetes Mellitus Inadequately Controlled by Oral Therapies

Year: 2015

Type: article

Source: Value in Health

DOI: 10.1016/j.jval.2015.09.2105

Authors: J Deng, S Gu, H Shao, H Dong, Y Zhao, L Shi

Institutions: Johns Hopkins University, Zhejiang University, Tulane University, Xavier University of Louisiana

Language: English

Topic: Diabetes Treatment and Management

Subfield: Endocrinology, Diabetes and Metabolism

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W3131144632

FWCI:

Cites:

Cited by:

Related to: 10